(MENAFNEditorial) AUSTIN, Texas, Dec. 13, 2017 /PRNewswire/ --Luminex Corporation (Nasdaq: ) (the "Company"), today announced that its board of directors declared a cash dividend for the fourth quarter of 2017 of $0.06 per share of common stock payableon January 12, 2018to stockholders of recordas of the close of business on December 22, 2017.
About Luminex Corporation
At Luminex, our mission is to empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health. We offer a wide range of solutions applicable in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and proteomic research, biodefense research, and food safety. We accelerate reliable answers while simplifying complexity and deliver certainty with a seamless experience. To learn more about Luminex, please visit us at .
Contacts:
Harriss Currie
Sr. Vice President of Finance and CFO
512.219.8020
Matthew Scalo
Sr. Director, Investor Relations
512.219.8020
View original content with multimedia:
SOURCE Luminex Corporation
MENAFN1312201700701241ID1096230569
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.